These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23448115)

  • 1. Cost-effectiveness of Medicare drug plans in schizophrenia and bipolar disorder.
    Smith KJ; Baik SH; Reynolds CF; Rollman BL; Zhang Y
    Am J Manag Care; 2013 Feb; 19(2):e55-63. PubMed ID: 23448115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost variability of suggested generic treatment alternatives under the Medicare Part D benefit.
    Patel RA; Walberg MP; Tong E; Tan F; Rummel AE; Woelfel JA; Carr-Lopez SM; Galal SM
    J Manag Care Spec Pharm; 2014 Mar; 20(3):283-90. PubMed ID: 24564812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in drug coverage generosity and untreated serious mental illness: transitioning from Medicaid to Medicare Part D.
    Madden JM; Adams AS; LeCates RF; Ross-Degnan D; Zhang F; Huskamp HA; Gilden DM; Soumerai SB
    JAMA Psychiatry; 2015 Feb; 72(2):179-88. PubMed ID: 25588123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generic-only drug coverage in the Medicare Part D gap and effect on medication cost-cutting behaviors for patients with diabetes mellitus: the translating research into action for diabetes study.
    Duru OK; Mangione CM; Hsu J; Steers WN; Quiter E; Turk N; Ettner SL; Schmittdiel JA; Tseng CW
    J Am Geriatr Soc; 2010 May; 58(5):822-8. PubMed ID: 20406312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse clinical events among medicare beneficiaries using antipsychotic drugs: linking health insurance benefits and clinical needs.
    Fung V; Price M; Busch AB; Landrum MB; Fireman B; Nierenberg A; Dow WH; Hui R; Frank R; Newhouse JP; Hsu J
    Med Care; 2013 Jul; 51(7):614-21. PubMed ID: 23752219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries.
    Choudhry NK; Patrick AR; Antman EM; Avorn J; Shrank WH
    Circulation; 2008 Mar; 117(10):1261-8. PubMed ID: 18285564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The introduction of generic risperidone in Medicare Part D.
    Fung V; Price M; Busch AB; Landrum MB; Fireman B; Nierenberg AA; Newhouse JP; Hsu J
    Am J Manag Care; 2016 Jan; 22(1):41-8. PubMed ID: 26799124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Higher Generic Drug Use and Medicare Part D Star Ratings: An Observational Analysis.
    Hohmann N; Hansen R; Garza KB; Harris I; Kiptanui Z; Qian J
    Value Health; 2018 Oct; 21(10):1186-1191. PubMed ID: 30314619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss.
    Treur M; Heeg B; Möller HJ; Schmeding A; van Hout B
    BMC Health Serv Res; 2009 Feb; 9():32. PubMed ID: 19226465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Economic analyses of olanzapine in the treatment of schizophrenia and bipolar disorder].
    Dilla T; Prieto L; Ciudad A; Sacristán JA
    Actas Esp Psiquiatr; 2004; 32(5):269-79. PubMed ID: 15529211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs.
    Newman-Casey PA; Woodward MA; Niziol LM; Lee PP; De Lott LB
    Ophthalmology; 2018 Mar; 125(3):332-339. PubMed ID: 28625684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential impact of pharmacist interventions to reduce cost for Medicare Part D beneficiaries.
    Thatcher EE; Vanwert EM; Erickson SR
    J Pharm Pract; 2013 Jun; 26(3):248-52. PubMed ID: 23178417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access to and use of $4 generic programs in Medicare.
    Zhang Y; Gellad WF; Zhou L; Lin YJ; Lave JR
    J Gen Intern Med; 2012 Oct; 27(10):1251-7. PubMed ID: 22311333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare Part D coverage gap and diabetes beneficiaries.
    Schmittdiel JA; Ettner SL; Fung V; Huang J; Turk N; Quiter ES; Swain BE; Hsu JT; Mangione CM
    Am J Manag Care; 2009 Mar; 15(3):189-93. PubMed ID: 19298100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generic replacement of clozapine: a simple decision model from a Canadian perspective.
    Layton S; Barbeau M
    Curr Med Res Opin; 2004 Apr; 20(4):453-9. PubMed ID: 15119982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of long-acting injectable aripiprazole once-monthly 400 mg in bipolar I disorder in the USA.
    Augusto M; Greene M; Touya M; Sweeney SM; Waters H
    J Comp Eff Res; 2018 Jul; 7(7):637-650. PubMed ID: 29694244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Medicare Part D coverage gap on medication and medical treatment among elderly beneficiaries with depression.
    Zhang Y; Baik SH; Zhou L; Reynolds CF; Lave JR
    Arch Gen Psychiatry; 2012 Jul; 69(7):672-9. PubMed ID: 22752233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes.
    Fung V; Mangione CM; Huang J; Turk N; Quiter ES; Schmittdiel JA; Hsu J
    Health Serv Res; 2010 Apr; 45(2):355-75. PubMed ID: 20050931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.